LEADER 00979nam a2200289 i 4500 001 991001285959707536 005 20020507113856.0 008 970308s1968 de ||| | eng 035 $ab10199354-39ule_inst 035 $aLE00645224$9ExL 040 $aDip.to Fisica$bita 084 $a53.2.24 084 $a539.7'35 084 $aQC721 100 1 $aSokolov, A.A.$0464213 245 10$aSynchrotron radiation /$cA.A. Sokolov, I.M. Ternov 260 $aBerlin :$bAkademie-Verlag ; Oxford : Pergamon Press,$c1968 300 $aviii, 202 p. :$bill. ;$c26 cm. 500 $aIncludes bibliographies. 650 4$aSynchrotron radiation 700 1 $aTernov, I.M. 907 $a.b10199354$b21-09-06$c27-06-02 912 $a991001285959707536 945 $aLE006 53.2.2 SOK$g1$i2006000045254$lle006$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i10246113$z27-06-02 996 $aSynchrotron radiation$9190874 997 $aUNISALENTO 998 $ale006$b01-01-97$cm$da $e-$feng$gde $h0$i1 LEADER 01553nas 22004933 450 001 996204782703316 005 20221206193531.0 011 $a2377-6625 035 $a(OCoLC)50326407 035 $a(CKB)111020957594036 035 $a(CONSER)--2015201790 035 $a(EXLCZ)99111020957594036 100 $a20020808b20002003 --- a 101 0 $aeng 135 $aurmnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aPharmaceutical innovation 210 1$aMontclair, N.J. :$cAdis International, Inc. 311 $a1537-1328 531 0 $aPharm. innov. 606 $aPharmaceutical technology$vPeriodicals 606 $aPharmaceutical industry$vPeriodicals 606 $aGene therapy$vPeriodicals 606 $aAntisense nucleic acids$vPeriodicals 606 $aAntisense nucleic acids$2fast$3(OCoLC)fst00810788 606 $aGene therapy$2fast$3(OCoLC)fst00939638 606 $aPharmaceutical industry$2fast$3(OCoLC)fst01060129 606 $aPharmaceutical technology$2fast$3(OCoLC)fst01060211 608 $aPeriodicals.$2fast 615 0$aPharmaceutical technology 615 0$aPharmaceutical industry 615 0$aGene therapy 615 0$aAntisense nucleic acids 615 7$aAntisense nucleic acids. 615 7$aGene therapy. 615 7$aPharmaceutical industry. 615 7$aPharmaceutical technology. 676 $a338 906 $aJOURNAL 912 $a996204782703316 996 $aPharmaceutical innovation$92493629 997 $aUNISA